(INNV) InnovAge Holding - Ratings and Ratios
Home Care, Health Services, Transportation, Therapy
INNV EPS (Earnings per Share)
INNV Revenue
Description: INNV InnovAge Holding
InnovAge Holding Corp (NASDAQ:INNV) is a healthcare services company that provides a comprehensive range of medical and ancillary services to seniors, enabling them to live independently in their communities. The companys Program of All-Inclusive Care for the Elderly (PACE) approach is a holistic model that addresses the complex needs of seniors, offering a continuum of care that includes in-home care, in-center services, transportation, and care management. With a presence in six states, including Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia, InnovAge is well-positioned to capitalize on the growing demand for senior care services.
The companys business model is centered around its PACE centers, which serve as a hub for delivering a wide range of services, including primary care, therapy services, dental care, mental health services, and activities. By providing a comprehensive and coordinated approach to care, InnovAge aims to improve health outcomes, reduce healthcare costs, and enhance the quality of life for its participants. With a strong focus on care management, the company is able to tailor its services to meet the unique needs of each individual, ensuring that they receive the right care at the right time.
From a technical analysis perspective, INNVs stock price is currently trading at $3.94, with a 20-day SMA of $3.88 and a 50-day SMA of $3.62, indicating a potential bullish trend. The stocks ATR is 0.21, representing a 5.44% volatility. Given the current technical setup and fundamental data, including a forward P/E of 13.66 and a market cap of $504.95M, a potential forecast for INNV is that the stock may experience a moderate increase in the short term, potentially reaching $4.50-$5.00, driven by the companys continued growth and expansion in the senior care market.
Furthermore, InnovAges growth prospects are supported by the increasing demand for senior care services, driven by the aging population in the United States. As the company continues to expand its PACE centers and services, it is well-positioned to capitalize on this trend, potentially driving long-term growth and returns for investors. With a strong foundation in the senior care market and a comprehensive approach to care, InnovAge is an attractive player in the healthcare services sector.
Additional Sources for INNV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
INNV Stock Overview
Market Cap in USD | 560m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2021-03-04 |
INNV Stock Ratings
Growth Rating | -75.5 |
Fundamental | -18.5 |
Dividend Rating | 0.0 |
Rel. Strength | -18.8 |
Analysts | 2.75 of 5 |
Fair Price Momentum | 3.49 USD |
Fair Price DCF | 2.48 USD |
INNV Dividends
Currently no dividends paidINNV Growth Ratios
Growth Correlation 3m | 68.5% |
Growth Correlation 12m | -75.4% |
Growth Correlation 5y | -64.6% |
CAGR 5y | -33.11% |
CAGR/Max DD 5y | -0.37 |
Sharpe Ratio 12m | -0.07 |
Alpha | -34.13 |
Beta | 0.507 |
Volatility | 68.90% |
Current Volume | 45.3k |
Average Volume 20d | 38k |
Stop Loss | 3.9 (-6.7%) |
As of July 16, 2025, the stock is trading at USD 4.18 with a total of 45,257 shares traded.
Over the past week, the price has changed by -1.65%, over one month by +13.59%, over three months by +48.23% and over the past year by -25.89%.
Neither. Based on ValueRay´s Fundamental Analyses, InnovAge Holding is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -18.45 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INNV is around 3.49 USD . This means that INNV is currently overvalued and has a potential downside of -16.51%.
InnovAge Holding has received a consensus analysts rating of 2.75. Therefor, it is recommend to hold INNV.
- Strong Buy: 0
- Buy: 0
- Hold: 3
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, INNV InnovAge Holding will be worth about 3.9 in July 2026. The stock is currently trading at 4.18. This means that the stock has a potential downside of -7.66%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 5 | 19.6% |
Analysts Target Price | 5 | 19.6% |
ValueRay Target Price | 3.9 | -7.7% |